No Data
No Data
No Data
No Data
No Data
MaxCyte Started at Hold by Deutsche Bank
MaxCyte Started at Hold by Deutsche Bank
Dow JonesMay 3 15:15
MaxCyte Schedules AGM Amidst Cell Therapy Innovations
TipRanksMay 3 14:40
MaxCyte Expands Stock Capital, Supports Cell Therapy
TipRanksMay 2 00:30
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth
Yahoo FinanceApr 17 16:35
MaxCyte to Report First Quarter 2024 Financial Results on May 7, 2024
ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development
GlobeNewswireApr 10 20:05
MaxCyte Signs Strategic Platform License With Be Biopharma to Support the Development of Engineer...
Stockhouse Apr 2 20:05
No Data
No Data